Significance and influencing factors of serum level of ummethylation
INSDNA in patients with newly diagnosed type 2 diabetes mellitus

doi:10.3760/cma.j.issn.1007-1245.2022.09.009

Abstract

Abstract: Objective　To investigate the significance and influencing factors of serum level of ummethylation insulin DNA (INSDNA) in patients with newly diagnosed type 2 diabetes mellitus (NT2DM) by case control study. Methods　Forty-five patients with NT2DM hospitalized at Department of Endocrinology, Dongguan Houjie Hospital from October 2018 to May 2020 were selected, including 30 males and 15 females, and they were (47.0±9.6) years old. There were 23 patients with long course T2DM (LT2DM), including 15 males and 8 females, and they were (48.6±8.6) years old. There were 20 patients with normal glucose tolerance (NGT), including 13 males and 7 females, and they were (40.2±5.5) years old. The serum level of unmethylated INSDNA was detected by drop digital polymerase chain reaction (ddPCR), and the levels of human cathepsin S (Cath-S) and interleukin 6 (IL-6) by enzyme linked immunosorbent assay (ELISA). One-way ANOVA was used to analyze the difference in the unmethylated INSDNA level between the three groups, and Spearman correlation analysis was used to analyze the correlation of unmethylated INSDNA level with fasting C peptide (FC), Cath-S, and IL-6. Independent-sample t test and χ² test were applied. Results　The serum level of unmethylated INSDNA in the patients with NT2DM was significantly higher than those in the patients with NGT and the patients with LT2DM [3.01 (4.64) copies/μl vs. 0.59 (0.19) copies/μl and 1.77 (2.80) copies/μl], with statistical differences (both P<0.01). The levels of Cath-S and IL-6 in the patients with NT2DM were significantly higher than those in the patients with NGT [683.37 (283.90) nmol/L vs. 479.70 (111.30) nmol/L and 28.95 (9.99) pg/ml vs. 3.42 (6.90) pg/ml; both P<0.01]. The correlation analysis showed that the level of unmethylated INSDNA was positively correlated with the levels of FC, Cath-S, and IL-6 in the patients with NT2DM (r=0.354, P=0.017; r=0.320, P=0.032; r=0.434, P=0.003). Conclusions　The serum level of unmethylated INSDNA is higher in patients with T2DM during early stage and decreases as the disease course prolongs. Serum Cath-S, IL-6, and FC may be important factors affecting the level of unmethylated INSDNA.

Key words: Serum unmethylated INSDNA, Newly diagnosed T2DM, Cath-S, IL-6

摘要： 目的　用病例对照研究血非甲基化胰岛素DNA（INSDNA）在新诊断2型糖尿病（NT2DM）中的意义及影响因素。方法　选择2018年10月至2020年5月在东莞市厚街医院内分泌科住院的NT2DM患者45例，其中男30例、女15例，年龄（47.0±9.6岁）；长病程2型糖尿病（LT2DM）患者23例，其中男15例、女8例，年龄（48.6±8.6岁）；糖耐量正常（NGT）20例，其中男13例、女7例，年龄（40.2±5.5岁）。用液滴数字PCR技术（ddPCR）检测血清非甲基化INSDNA及ELSA检测人组织蛋白酶S（Cath-S）和白介素6（IL-6）水平，采用单因素方差分析各组非甲基化INSDNA水平差异及用Spearman相关分析空腹C肽（FC）、Cath-S、IL-6与非甲基化INSDNA水平的相关性。统计学方法采用独立样本t检验、χ²检验。结果　NT2DM组患者的血清非甲基化INSDNA水平明显高于NGT组和LT2DM组［3.01（4.64）copies/μl比0.59（0.19）copies/μl、1.77（2.80）copies/μl］，差异均有统计学意义（均P<0.01）。NT2DM组的患者Cath-S水平［683.37（283.90）nmol/L比479.70（111.30）nmol/L］、IL-6水平［28.95（9.99）pg/ml比3.42（6.90）pg/ml）］均明显高于NGT组（均P<0.01）。相关分析显示，非甲基化INSDNA水平在NT2DM患者与Cath-S、IL-6和FC呈正相关（r=0.354，P=0.017；r=0.320，P=0.032；r=0.434，P=0.003）。结论　血清非甲基化INSDNA水平在NT2DM疾病早期水平较高，随着病程延长而降低，血Cath-S、IL-6和FC可能是影响NT2DM血清非甲基化INSDNA水平的重要因素。

关键词: 血清非甲基化INSDNA, 新诊断T2DM, Cath-S, IL-6

Wang Shaobo, Bao Liwen, Yin Liming, Deng Li, Fu Wenjin. Significance and influencing factors of serum level of ummethylation INSDNA in patients with newly diagnosed type 2 diabetes mellitus[J]. International Medicine and Health Guidance News, 2022, 28(9): 1222-1226.

王少波, 包利文, 尹丽明, 邓黎, 付文金. 新诊断2型糖尿病患者血清非甲基化胰岛素DNA水平的意义及其影响因素[J]. 国际医药卫生导报, 2022, 28(9): 1222-1226.

References

[1] Davegårdh C, García-Calzón S, Bacos K, et al. DNA methylation in the pathogenesis of type 2 diabetes in humans[J]. Mol Metab,2018,14:12-25. DOI: 10.1016/j.molmet.2018.01.022.

[2] Fisher MM, Watkins RA, Blum J, et al. Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes[J]. Diabetes,2015,64(11):3867-3872. DOI: 10.2337/db15-0430.

[3] Yang BT, Dayeh TA, Kirkpatrick CL, et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets[J].Diabetologia,2011, 54(2):360-367. DOI: 10.1007/s00125-010-1967-6.

[4] Husseiny MI, Kuroda A, Kaye AN, et al. Development of a quantitative methylation-specific polymerase chain reaction method formonitoring Beta cell death in type 1 diabetes[J]. PLoS One, 2012, 7(10):e47942. DOI: 10.1371/journal.pone.0047942.

[5] Lappas M, Georgiou HM, Willcox JC,et al. Postpartum circulating cell-free insulin DNA levels are higher in women with previous gestational diabetes mellitus who develop type 2 diabetes in later life [J]. J Diabetes Res, 2019, 2019:3264184. DOI: 10.1155/2019/3264184.

[6] T Tersey SA, Nelson JB, Fisher MM, et al. Measurement of differentially methylated INS DNA species in human serum samples as a biomarker ofislet βcell death[J]. J Vis Exp,2016,21(118):e54838. DOI: 10.3791/54838.

[7] Kenna LA, Olsen JA, Spelios MG, et al. Beta cell death is decreased in women with gestational diabetes mellitus[J]. Diabetol Metab Syndr,2016, 8(1):60. DOI: 10.1186/s13098-016-0175-z.

[8] G Gilbert ER, Liu D. Epigenetics the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes[J]. Epigenetics, 2012,7 (8):841-852. DOI: 10.4161/epi.21238.

[9] Lebastchi J, Deng S, Lebastchi AH, et al. Immune therapy and β-cell death in type 1 diabetes[J]. Diabetes, 2013, 62(5):1676-80. DOI: 10.2337/db12-1207.

[10] Husseiny MI, Kaye A, Zebadua E, et al. Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death[J]. PloS one, 2014,9 (4):e94591. DOI: 10.1371/journal.pone.0094591.

[11] Bellin MD, Clark P, Usmani-Brown S, et al. Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker[J]. Am J Transplant,2017, 17(4): 1112-1118. DOI: 10.1111/ajt.14054.

[12] Moreira VG, Prieto B, Rodríguez JS, et al. Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients[J]. Ann Clin Biochem, 2010, 47(Pt 3): 253-258. DOI: 10.1258/acb.2010.009173.

[13] Kuroda A, Rauch TA, Todorov I, et al. Insulin gene expression is regulated by DNA methylation[J]. PloS one,2009, 4(9): e6953. DOI: 10.1371/journal.pone.0006953.

[14] Elmore S. Apoptosis: a review of programmed cell death[J]. Toxicol Pathol, 2007,35(4):495-516. DOI: 10.1080/01926230701320337.

[15] Marroqui L, Masini M, Merino B, et al.Pancreatic α cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes[J]. EBioMedicine,2015, 2(5):378-385. DOI: 10.1016/j.ebiom.2015.03.012.

[16] Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell defificit and increased beta-cell apoptosis in humans with type 2 diabetes[J]. Diabetes, 2003,52 (1):102-110. DOI: 10.2337/diabetes.52.1.102.

[17] Kim WH, Lee JW, Suh YH, et al. Exposure to chronic high glucose induces beta-cell apoptosis through decreased interaction of glucokinase with mitochondria: downregulation of glucokinase in pancreatic beta-cells[J]. Diabetes, 2005,54(9):2602-2611. DOI: 10.2337/diabetes.54.9.2602.

[18] Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes[J]. Diabetologia, 2005,48:1038-1050. DOI 10.1007/s00125-005-1764-9.

[19] 吴晓青,郝立鹏,张有涛,等. 荷术饮联合达格列净治疗对糖尿病患者糖化血红蛋白与β细胞功能的影响[J]. 国际医药卫生导报,2020,26(17):2531-2535. DOI:10.3760/cma.j.issn.1007-1245.2020.17.010.

[20] Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein,interleukin-6, and risk of developingtype 2 diabetes mellitus[J]. JAMA, 2001, 286(3):327-334. DOI: 10.1001/jama.286.3.327.

[21] Sandler S, Bendtzen K, Eizirik DL, et al. Interleukin-6 affects insulinsecretion and glucose metabolism of ratpancreatic islets in vitro[J]. Endocrinology,1990, 126(2):1288-1294. DOI: 10.1210/endo-126-2-1288.

[22] Taleb S,Cancello R,Clément K, et al. Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation[J]. Endocrinology,2006,147(10):4950-4959. DOI: 10.1210/en.2006-0386.

[23] Lafarge JC, Pini M, Pelloux V, et al. Cathepsin s inhibition lowers blood glucose levels in mice[J]. Diabetologia, 2014, 57(8): 1674-1683. DOI: 10.1007/s00125-014-3280-2.

[24] Rodgers KJ, Watkins DJ, Miller AL, et al. Destabilizing role of cathepsinS in murine atherosclerotic plaques[J]. Arterioscler Thromb Vasc Biol,2006, 26(4):851-856. DOI: 10.1161/01.ATV.0000203526.75772.4b.

[25] Kumar Vr S, Darisipudi MN, Steiger S, et al. Cathepsin s cleavage of protease-activated receptor-2 on endothelial cells promotes microvascular diabetes complications[J]. J Am Soc Nephrol, 2016, 27(6):1635-1649. DOI: 10.1681/ASN.2015020208.

Significance and influencing factors of serum level of ummethylation INSDNA in patients with newly diagnosed type 2 diabetes mellitus

新诊断2型糖尿病患者血清非甲基化胰岛素DNA水平的意义及其影响因素

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics